DArecca James (CIK 1583903) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-05). Recent activity: Buy PBH (2,981 shares), Sell HAE (2,505 shares), Buy HAE (29,312 shares), Sell HAE (655 shares), Buy PBH (2,094 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Prestige Consumer Healthcare Inc. (PBH) | Director | Buy | 2,981 | $0 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 2,505 | $141,006 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Buy | 29,312 | $0 |
| 2026-05-05 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 655 | $38,815 |
| 2025-08-06 | Prestige Consumer Healthcare Inc. (PBH) | Director | Buy | 2,094 | $0 |
| 2025-06-03 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Buy | 12,221 | $0 |
| 2025-06-03 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 5,864 | $406,844 |
| 2025-05-20 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Buy | 7,111 | $0 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 622 | $43,154 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 1,246 | $87,606 |
| 2025-05-05 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | Sell | 654 | $41,758 |
Source: SEC Form 4 filings · as of 2026-08-05